Cronos Group Announces Strategic Investment in PharmaCann, a Leading U.S. Cannabis Company Investment is Expected to Position Cronos Group to Benefit from Rapid Growth in the U.S. Cannabis Market PharmaCann...

Exclusive Interview with PharmaCann CEO Brett Novey Privately held MSO PharmaCann is building a cohesive footprint stretching from Illinois to the East Coast. CEO Brett Novey spoke with New...

Although Ohio legalized medical use of cannabis four years ago, the state has been slow to grow its program. Myriad regulations, along with delays in awarding licenses, kept the...